EU actions to tackle shortages of GLP-1 receptor agonists

View source ↗

Summary

EMA outlines recommendations from the Multi-Stakeholder Supply Group (MSSG) and actions to address shortages of GLP-1 receptor agonists in the EU, and announces…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lyxumia (lixisenatide)
• OZEMPIC (semaglutide)
• Rybelsus (semaglutide)
• TRULICITY (DULAGLUTIDE)
• Victoza (Liraglutide)
• WEGOVY (Semaglutide)

Snippet

MSSG recommendations for all stakeholders and upcoming multistakeholder workshop